These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 36163606)

  • 1. A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome Engineering.
    Hillary VE; Ceasar SA
    Mol Biotechnol; 2023 Mar; 65(3):311-325. PubMed ID: 36163606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-cas technology: A key approach for SARS-CoV-2 detection.
    Fang L; Yang L; Han M; Xu H; Ding W; Dong X
    Front Bioeng Biotechnol; 2023; 11():1158672. PubMed ID: 37214290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of the CRISPR-Cas system for infectious disease diagnostics.
    Li P; Wang L; Yang J; Di LJ; Li J
    Expert Rev Mol Diagn; 2021 Jul; 21(7):723-732. PubMed ID: 33899643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The next generation of CRISPR-Cas technologies and applications.
    Pickar-Oliver A; Gersbach CA
    Nat Rev Mol Cell Biol; 2019 Aug; 20(8):490-507. PubMed ID: 31147612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
    Singh M; Bindal G; Misra CS; Rath D
    Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
    Khanzadi MN; Khan AA
    J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR systems: Novel approaches for detection and combating COVID-19.
    Safari F; Afarid M; Rastegari B; Borhani-Haghighi A; Barekati-Mowahed M; Behzad-Behbahani A
    Virus Res; 2021 Mar; 294():198282. PubMed ID: 33428981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid.
    Li X; Zhong J; Li H; Qiao Y; Mao X; Fan H; Zhong Y; Imani S; Zheng S; Li J
    Front Mol Biosci; 2023; 10():1260883. PubMed ID: 37808520
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of applications of CRISPR-Cas technologies in biomedical engineering.
    Jamehdor S; Zaboli KA; Naserian S; Thekkiniath J; Omidy HA; Teimoori A; Johari B; Taromchi AH; Sasano Y; Kaboli S
    Folia Histochem Cytobiol; 2020; 58(3):163-173. PubMed ID: 32978771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-Targeting CRISPR-Cas Systems and Their Applications.
    Burmistrz M; Krakowski K; Krawczyk-Balska A
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of CRISPR-based programmable RNA manipulation and detection.
    Wang B; Yang H
    Wiley Interdiscip Rev RNA; 2023; 14(6):e1804. PubMed ID: 37282821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas-Mediated Genome Engineering in Plants: Application and Prospectives.
    Mishra S; Nayak S; Tuteja N; Poosapati S; Swain DM; Sahoo RK
    Plants (Basel); 2024 Jul; 13(14):. PubMed ID: 39065411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications.
    Siew WS; Tang YQ; Kong CK; Goh BH; Zacchigna S; Dua K; Chellappan DK; Duangjai A; Saokaew S; Phisalprapa P; Yap WH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas Systems: Programmable Nuclease Revolutionizing the Molecular Diagnosis.
    Pandya K; Jagani D; Singh N
    Mol Biotechnol; 2024 Aug; 66(8):1739-1753. PubMed ID: 37466850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique.
    Ghosh N; Saha I; Sharma N
    Gene; 2022 Apr; 818():146136. PubMed ID: 34999179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems.
    Aquino-Jarquin G
    Drug Discov Today; 2023 Nov; 28(11):103793. PubMed ID: 37797813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets.
    Su W; Li J; Ji C; Chen C; Wang Y; Dai H; Li F; Liu P
    Nano Res; 2023 Mar; ():1-14. PubMed ID: 37359078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short overview of CRISPR-Cas technology and its application in viral disease control.
    Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
    Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.